NCT00869440View on ClinicalTrials.gov

Dose-Finding Safety Study Evaluating Remimazolam (CNS 7056) in Patients Undergoing Diagnostic Upper GI Endoscopy

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Procedural SedationEndoscopy
Interventions
DRUG

CNS 7056

Administered as a single intravenous injection by a syringe driver over 1 minute

DRUG

Midazolam

Administered as a single intravenous injection by a syringe driver over 1 minute

Trial Locations (7)

11794

Stony Brook University Medical Center, Stony Brook

22911

Charlottesville Medical Research, Charlottesville

27612

Wake Research Associates, Raleigh

33143

Miami Research Associates, South Miami

35660

Helen Keller Hospital, Sheffield

85050

HOPE Research Institute, Phoenix

92801

Advanced Clinical Research Institute, Anaheim

Sponsors
All Listed Sponsors
collaborator

Premier Research Group plc

UNKNOWN

lead

Paion UK Ltd.

INDUSTRY

NCT00869440 - Dose-Finding Safety Study Evaluating Remimazolam (CNS 7056) in Patients Undergoing Diagnostic Upper GI Endoscopy | Biotech Hunter | Biotech Hunter